Results
23
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
23 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ALNOV | €0.61 | -15.8% | -15.8% | €43.1m | n/a | PS1.9x | n/a | n/a | ||
ALTME | €0.065 | -18.0% | -71.3% | €2.7m | €0.61 | PB1.7x | S29.9% | n/a | ||
AELIS | €2.18 | -9.2% | -83.6% | €29.7m | €9.10 | PS2.8x | E33.8% | n/a | ||
SAN | €91.80 | 0.6% | 2.9% | €115.1b | €113.80 | PE25.5x | E16.8% | 4.1% | ||
ALSEN | €0.64 | -7.2% | 42.9% | €192.2m | €2.38 | PS31.3x | E-31.5% | n/a | ||
ABNX | €1.25 | -3.6% | -3.4% | €43.3m | €11.50 | PS8.9x | E-23.4% | n/a | ||
ALVAL | €1.36 | 4.9% | -70.7% | €21.5m | €6.35 | PS40.8x | E59.3% | n/a | ||
BOI | €27.00 | 2.3% | -34.9% | €468.8m | €33.30 | PE19.8x | E26.2% | 5.0% | ||
IPN | €109.50 | -0.09% | 2.5% | €9.0b | €129.50 | PE13.6x | E6.9% | 1.1% | ||
VIRP | €313.00 | -3.7% | -11.6% | €2.6b | €402.94 | PE18.6x | E10.8% | 0.4% | ||
ABVX | €7.48 | -3.5% | -24.1% | €473.8m | €29.94 | PS52.5x | E1.9% | n/a | ||
ALERS | €23.80 | -7.6% | 50.1% | €239.0m | €30.00 | PE36x | E29.0% | n/a | ||
MAAT | €8.10 | 1.5% | 17.1% | €112.7m | €16.70 | PS43.9x | E-3.3% | n/a | ||
OSE | €7.17 | -11.4% | 74.9% | €156.0m | €12.64 | PE3.4x | E-72.5% | n/a | ||
ALCLS | €1.56 | -15.5% | -53.2% | €155.7m | n/a | PS4.5x | E21.9% | n/a | ||
VETO | €76.70 | -1.3% | -23.9% | €907.6m | €96.57 | PE19.3x | E8.9% | 1.1% | ||
GNFT | €3.50 | -1.8% | -1.5% | €174.3m | €9.45 | PE7.8x | E41.2% | n/a | ||
ALGEN | €3.92 | -2.0% | -13.7% | €35.3m | n/a | PE28.1x | n/a | n/a | ||
DBV | €0.60 | -6.3% | -67.5% | €58.4m | €2.46 | PS4.9x | E7.4% | n/a | ||
ALECR | €20,000.00 | 0% | -20.0% | €100.9m | n/a | PE13.2x | n/a | n/a | ||
ERF | €47.59 | -0.5% | -19.7% | €9.0b | €59.46 | PE27.7x | E18.4% | 1.1% | ||
EAPI | €2.80 | -12.5% | -48.8% | €266.7m | €3.38 | PS0.3x | E69.2% | n/a | ||
IPH | €1.98 | 23.5% | -25.4% | €160.0m | €6.25 | PS4.7x | E36.6% | n/a |